Basic Information
| LncRNA/CircRNA Name | RP11-119F7.4 |
| Synonyms | RP11-119F7.5 |
| Region | GRCh38_10:68698500-68700794 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR etc. |
| Sample | gastric cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | RP11-119F7.4 expression was significantly downregulated in the gastric cancer tissues compared with the matched NATs and was significantly associated with the macroscopic type and Lauren grade. LncRNA RP11-119F7.4 may be involved in carcinogenesis and may prove useful as a biomarker for diagnosis and prognostic significance in patients with gastric cancer. |
| Pubmed ID | 26170986 |
| Year | 2015 |
| Title | Novel long non-coding RNA RP11-119F7.4 as a potential biomarker for the development and progression of gastric cancer. |
External Links
| Links for RP11-119F7.4 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |